In addition, the DDR, PI3K and Wnt pathways were altered in nearly 10.62%, 6.01%, and 6.01% of the PRAD patient samples from the TCGA-PRAD cohort (Fig. 6F–H). Here, PIK3CA is linked to prostate adenocarcinoma.